Barbara Ellers‐Lenz

1.4k citations
28 papers · 964 indexed · 1 hit paper · h-index 13

Barbara Ellers‐Lenz

27 papers receiving 943 citations

Hit Papers

Avelumab versus docetaxel in patients with platinum-treat...3362018202620202023100200300

Peers

Barbara Ellers‐Lenz
Comparison fields: 5 of 77
  • Oncology 599
  • Neurology 90
  • Pulmonary and Respiratory Medicine 337
  • Immunology and Allergy 55
  • Sensory Systems 43
Replace A. Nagano with:
A. Nagano United Kingdom
Christina M. Reinisch Austria
Deborah Ritter United States
Elena Magrini Italy
Raquel Planas Spain
Christian Lang Germany
Harold Koendgen Switzerland
Weixiang Zhong China
Kristyn Gumpper United States
Rebecca S. Cook United States
Barbara Ellers‐Lenz relative to A. Nagano United Kingdom A. Nagano's profile →
Citations per field
00.5×10×15×21.5×
A. Nagano · 1×
Citations per year

Countries citing papers authored by Barbara Ellers‐Lenz

Since Specialization
Citations

This map shows the geographic impact of Barbara Ellers‐Lenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Ellers‐Lenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Ellers‐Lenz more than expected).

Fields of papers citing papers by Barbara Ellers‐Lenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Ellers‐Lenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Ellers‐Lenz. The network helps show where Barbara Ellers‐Lenz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Barbara Ellers‐Lenz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Ellers‐Lenz Line = papers co-authored together Barbara Ellers‐Lenz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20231
2 202227
3 20210
4 202180
5 202120
6 20211
7 20201
8 20202
9 2020134
10 201910
11
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 studybreakdown →
2018336
12 20181
13 20176
14 20173
15 201139
16 20112
17 200711
18 200422
19 200321
20 200014

About Barbara Ellers‐Lenz

Barbara Ellers‐Lenz is a scholar working on Immunology and Allergy, Oncology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 964 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (7 papers), Allergic Rhinitis and Sensitization (4 papers), Polyomavirus and related diseases (4 papers), Ocular Surface and Contact Lens (4 papers), Asthma and respiratory diseases (3 papers) and Full-Duplex Wireless Communications (3 papers). The work is most often cited by research in Oncology (599 citations), Neurology (90 citations) and Pulmonary and Respiratory Medicine (337 citations). Barbara Ellers‐Lenz has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Marcis Bajars, Filippo de Marinis, Hidenobu Ishii, Andreas Polychronis, Maciej Krzakowski, Jong Seok Lee, Keunchil Park, David R. Spigel, Fabrice Barlési and Mustafa Özgüroğlu. Their work appears in journals such as Journal of Clinical Oncology, Neurology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026